Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Factor X”

Showing 20 of 0 results

Not applicableStudy completedNCT02190149
What this trial is testing

Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBIS

Who this might be right for
Hemophilia AHemophilia B
Baxalta now part of Shire 64
Early research (Phase 1)Not Yet RecruitingNCT03961243
What this trial is testing

Lentiviral FIX Gene Therapy

Who this might be right for
Hemophilia B
Shenzhen Geno-Immune Medical Institute 10
Large-scale testing (Phase 3)Study completedNCT01507896
What this trial is testing

BAX 326 Surgery Study in Hemophilia B Patients

Who this might be right for
Hemophilia B
Baxalta now part of Shire 30
Early research (Phase 1)Study completedNCT01562457
What this trial is testing

Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding State

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 30
Early research (Phase 1)Study completedNCT00956345
What this trial is testing

Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia B

Who this might be right for
Congenital Bleeding DisorderHaemophilia B
Novo Nordisk A/S 18
Not applicableUnknownNCT03533504
What this trial is testing

Web Accessible Population Pharmacokinetics Service - Hemophilia: Sources of Variability

Who this might be right for
Hemophilia AHemophilia B
McMaster University 1,000
Testing effectiveness (Phase 2)Ended earlyNCT03369444
What this trial is testing

A Factor IX Gene Therapy Study (FIX-GT)

Who this might be right for
Hemophilia B
University College, London 10
Large-scale testing (Phase 3)Study completedNCT00768287
What this trial is testing

Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B

Who this might be right for
Hemophilia B
Medexus Pharma, Inc. 77
Large-scale testing (Phase 3)Study completedNCT03587116
What this trial is testing

Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

Who this might be right for
Hemophilia BHemophilia A
Pfizer 212
Testing effectiveness (Phase 2)Study completedNCT03091751
What this trial is testing

Efficacy and Safety of AlphaNine Versus BeneFIX in Patients With Severe Hereditary Haemophilia B

Who this might be right for
Hemophilia B
Grifols Biologicals, LLC 13
Large-scale testing (Phase 3)Looking for participantsNCT05611801
What this trial is testing

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

Who this might be right for
Hemophilia AHemophilia B
Pfizer 100
Large-scale testing (Phase 3)Active Not RecruitingNCT05203679
What this trial is testing

Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy Drug

Who this might be right for
Hemophilia B
Shanghai Xinzhi BioMed Co., Ltd. 32
Testing effectiveness (Phase 2)Study completedNCT03307980
What this trial is testing

Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 21
Not applicableStudy completedNCT01661010
What this trial is testing

The Clinical Study of Sex Chromosome Variants

Who this might be right for
Male Factor InfertilityFemale Factor Infertility
National Human Genome Research Institute (NHGRI) 112
Post-approval studies (Phase 4)UnknownNCT04534751
What this trial is testing

Factor In the Initial Resuscitation of Severe Trauma 2 Patients

Who this might be right for
Traumatic HemorrhageCoagulopathyMassive Hemorrhage
University Health Network, Toronto 350
Not applicableUnknownNCT06158334
What this trial is testing

Study of Surgical Practices in Patients With Haemophilia A or B Treated With an Extended Half-life Recombinant Factor VIII-Fc or IX-Fc (ELOCTA®, ALPROLIX®)

Who this might be right for
Hemophilia AHemophilia B
Hospices Civils de Lyon 400
Testing effectiveness (Phase 2)Study completedNCT00004801
What this trial is testing

Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency

Who this might be right for
Hemophilia BFactor IX Deficiency
National Center for Research Resources (NCRR) 3
Testing effectiveness (Phase 2)Study completedNCT02396342
What this trial is testing

Trial of AAV5-hFIX in Severe or Moderately Severe Hemophilia B

Who this might be right for
Hemophilia B
CSL Behring 10
Large-scale testing (Phase 3)Study completedNCT00093171
What this trial is testing

Study Evaluating rFIX; BeneFIX® in Hemophilia B

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 23
Testing effectiveness (Phase 2)Study completedNCT03995784
What this trial is testing

Study of Next-Generation Recombinant Factor IX Variant in Adult Subjects With Hemophilia B

Who this might be right for
Hemophilia B
Catalyst Biosciences 6
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation